ABCL
AbCellera Biologics Inc.
ABCL
AbCellera Biologics Inc.
Biotech, especially small-cap names, is experiencing renewed optimism as macro and policy headwinds subside, driving sector-wide rallies. Stabilization at the FDA and a resurgence in M&A and IPO activ
AbCellera Biologics Inc. (ABCL) Q2 2026 Earnings Call Transcript
Biotech stocks are consolidating after a breakout, with bullish insider Wall Street sentiment. AbCellera Biologics and Alpha Cognition stand out for insider buying, revenue growth, and high Seeking Al